The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors

Journal of Dermatological Science

Volumn 60, Issue 1, 2010, Pages 29-39

  Arun, Senthil Nathan ^a   Xie, Ding ^a   Dodd, M Ernest ^a   Zhong, Xiaofeng ^a   Bollag, Wendy B ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Keratinocytes; Protein kinase C (PKC); Protein kinase D (PKD); Resveratrol; Skin; Transglutaminase

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; CALCITRIOL; CID 755673; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE D INHIBITOR; PROTEIN KINASE INHIBITOR; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER PREVENTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SELECTIVITY; EPIDERMIS; EPIDERMIS TUMOR; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TUMOR; WESTERN BLOTTING;

ANIMALS; ANTICARCINOGENIC AGENTS; CARBAZOLES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EPIDERMIS; ISOQUINOLINES; KERATINOCYTES; MICE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; SKIN NEOPLASMS; STILBENES; SULFONAMIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 77957021002     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.07.015     Document Type: Article

References (40)

1. Delclos K.B., Nagle D.S., Blumberg P.M. Specific binding of phorbol ester tumor promoters to mouse skin. Cell 1980, 19:1025-1032.
2. Yuspa S.H., Hennings H., Saffiotti U. Cutaneous chemical carcinogenesis: past, present, and future. J Invest Dermatol 1976, 67(1):199-208.
3. Goerttler K., Loehrke H., Schweizer J., Hesse B. Systemic two-stage carcinogenesis in the epithelium of the forestomach of mice using 7,12-dimethylbenz(a)anthracene as initiator and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter. Cancer Res 1979, 39(4):1293-1297.
4. Rubin H. Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis. Oncogene 2002, 21(48):7392-7411.
5. Ron D., Kazanietz M.G. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 1999, 13(13):1658-1676.
6. Van Lint J., Sinnett-Smith J., Rozengurt E. Expression and characterization of PKD, a phorbol ester and diacylglycerol-stimulated serine protein kinase. J Biol Chem 1995, 270:1455-1461.
7. Bollag W.B., Dodd M.E., Shapiro B.A. Protein kinase D and keratinocyte proliferation. Drug News Perspect 2004, 17:117-126.
8. Storz P., Toker A. Protein kinase D mediates a stress-induced NF-kB activation and survival pathway. EMBO J 2003, 22:109-120.
9. Storz P., Döppler H., Toker A. Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling. Mol Cell Biol 2004, 24:2614-2626.
10. Van Lint J., Rykx A., Maeda Y., Vantus T., Sturany S., Malhotra V., et al. Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol 2002, 12:193-200.
11. Vega R.B., Harrison B.C., Meadows E., Roberts C.R., Papst P.J., Olson E.N., et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 2004, 24:8374-8385.
12. Rennecke J., Rehberger P.A., Fürstenberger G., Johannes F.-J., Stöhr M., Marks F., et al. Protein kinase-Cμ expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture. Int J Cancer 1999, 80:98-103.
13. Dodd M.E., Ristich V.L., Ray S., Lober R.M., Bollag W.B. Regulation of protein kinase D during differentiation and proliferation of primary mouse keratinocytes. J Invest Dermatol 2005, 125:294-306.
14. Ristich V.L., Bowman P.H., Dodd M.E., Bollag W.B. Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br J Dermatol 2006, 154:586-593.
15. Shapiro B.A., Ray S., Jung E.M., Allred W.T., Bollag W.B. Putative conventional protein kinase C inhibitor Gödecke 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] stimulates transglutaminase activity in primary mouse epidermal keratinocytes. J Pharmacol Exp Ther 2002, 302:352-358.
16. Ivanova P., Atanasova G., Poumay Y., Mitev V. Knockdown of PKD1 in normal human epidermal keratinocytes increases mRNA expression of keratin 10 and involucrin: early markers of keratinocyte differentiation. Arch Dermatol Res 2008, 300:139-145.
17. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenovirus. Proc Natl Acad Sci USA 1998, 95:2509-2514.
18. Waldron R.T., Iglesias T., Rozengurt E. Phosphorylation-dependent protein kinase D activation. Electrophoresis 1999, 20:382-390.
19. Bollag W.B., Ducote J., Harmon C.S. Effects of the selective protein kinase C inhibitor, Ro 31-7549, on the proliferation of cultured mouse epidermal keratinocytes. J Invest Dermatol 1993, 100:240-246.
20. Sharlow E.R., Giridhar K.V., La Valle C.R., Chen J., Leimgruber S., Barrett R., et al. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone. J Biol Chem 2008, 283:33516-33526.
21. Matthews S.A., Rozengurt E., Cantrell D. Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/protein kinase Cμ. J Biol Chem 1999, 274:26543-26549.
22. Torres-Marquez E., Sinnett-Smith J., Guha S., Kui R., Waldron R.T., Rey O., et al. CID755673 enhances mitogenic signaling by phorbol esters, bombesin and EGF through a protein kinase D-independent pathway. Biochem Biophys Res Commun 2010, 391:63-68.
23. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990, 265(9):5267-5272.
24. Reuben P.M., Sun Y., Cheung H.S. Basic calcium phosphate crystals activate p44/42 MAPK signal transduction pathway via protein kinase Cmicro in human fibroblasts. J Biol Chem 2004, 279:35719-35725.
25. Stewart J.R., Christman K.L., O'Brian C.A. Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme phosphorylation. Biochem Pharmacol 2000, 60:1355-1359.
26. Slater S.J., Seiz J.L., Cook A.C., Stagliano B.A., Buzas C.J. Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta 2003, 1637(1):59-69.
27. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H.J., Johannes F.-J. Inhibition of protein kinase C mu by various inhibitors: Differentiation from protein kinase C isoenzymes. FEBS Lett 1996, 392:77-80.
28. Yuspa S.H., Ben T., Patterson E., Michael D., Elgjo K., Hennings H. Stimulated DNA synthesis in mouse epidermal cell cultures treated with 12-O-tetradecanoyl-phorbol-13-acetate. Cancer Res 1976, 36:4062-4068.
29. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 1993, 268(13):9194-9197.
30. Stempka L., Girod A., Muller H.J., Rincke G., Marks F., Gschwendt M., et al. Phosphorylation of protein kinase Cdelta (PKCdelta) at threonine 505 is not a prerequisite for enzymatic activity. Expression of rat PKCdelta and an alanine 505 mutant in bacteria in a functional form. J Biol Chem 1997, 272(10):6805-6811.
31. Iglesias T., Waldron R.T., Rozengurt E. Identification of in vivo phosphorylation sites required for protein kinase D activation. J Biol Chem 1998, 273:27662-27667.
32. Yuspa S.H., Hennings H., Kulesz-Martin M., Lichti U. The study of tumor promotion in a cell culture model for mouse skin-a tissue that exhibits multistage carcinogenesis in vivo. Carcinog Compr Surv 1982, 7:217-230.
33. Raick A.N., Thumm K., Chivers R.B. Early effects of 12-O-tetradecanoyl-phorbol-13-acetate on the incorporation of tritiated precursor into DNA and the thickness of the interfollicular epidermis, and their relation to tumor promotion in mouse skin. Cancer Res 1972, 32:1562-1568.
34. Yuspa S.H., Ben T., Hennings H., Lichti U. Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1982, 42:2344-2349.
35. Parkinson E.K. Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumour promotion by phorbol esters and by deep skin wounding. Br J Cancer 1985, 52(4):479-493.
36. Przybyszewski J., Box H.C., Kulesz-Martin M. Induction of reactive oxygen species without 8-hydroxydeoxyguanosine formation in DNA of initiated mouse keratinocytes treated with 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 1998, 19:1467-1474.
37. Diaz Anel A.M., Malhotra V. PKCeta is required for beta1gamma2/beta3gamma2- and PKD-mediated transport to the cell surface and the organization of the Golgi apparatus. J Cell Biol 2005, 169(1):83-91.
38. Ohba M., Ishino K., Kashiwagi M., Kawabe S., Chida K., Huh N., et al. Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the η and δ isoforms of protein kinase C. Mol Cell Biol 1998, 18:5199-5207.
39. Cho-Chung Y.S., Nesterova M.V. Tumor reversion: protein kinase A isozyme switching. Ann N Y Acad Sci 2005, 1058:76-86.
40. Blander G., Bhimavarapu A., Mammone T., Maes D., Elliston K., Reich C., et al. SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol 2009, 129:41-49.